Correlations between the ICIQ-SF score and urodynamic findings.
OBJECTIVE
The primary aim of this prospective study was to examine the correlations between "The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)" score and urodynamic findings in patients with urge incontinence. In addition, we aimed to observe the alterations of these parameters with antimuscarinic therapy.


METHODS
Between January and December 2005, patients referred to our department with urge incontinence were examined. After taking a detailed clinical history, physical examination, and urinalysis, each patient was asked to complete an ICIQ-SF questionnaire. We carried out subtracted cystometry according to a fixed protocol on all patients. Patients who were defined as detrusor overactivity incontinent were given antimuscarinic therapy for 3 months. Following treatment, filling cystometry and ICIQ-SF scoring were repeated in all patients. All pre- and post-treatment data of 18 male and 42 female patients were transferred to the SPSS 11.0 for Windows program, and statistical analyses were performed.


RESULTS
The patients' ages ranged from 28 to 70 (mean 49.8) years. We found statistically significant differences between the pre- and post-treatment parameters (mean ICIQ-SF score, first sensation, cystometric capacity, maximum detrusor pressure, compliance; P<0.01). We found negative correlation between pre-treatment mean ICIQ-SF score and first sensation (correlation coefficient -0.266, P<0.05) and positive correlation between pre-treatment mean ICIQ-SF score and maximum detrusor pressure (correlation coefficient 0.4, P<0.01).


CONCLUSIONS
ICIQ-SF scoring is a practical and reliable method for baseline and post-treatment evaluation of patients with urge incontinence. Significant correlation exists between ICIQ-SF score and urodynamic parameters.
Seckiner
Ilker
I
Department of Urology, Gaziantep University, Gaziantep, Turkey.
Yesilli
Cetin
C
Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
Mungan
N Aydin
NA
Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
Aykanat
Adem
A
Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
Akduman
Bulent
B
Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
D000328:Adult; D000368:Aged; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D003187:Compliance; D003408:Cresols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D011312:Pressure; D011788:Quality of Life; D011795:Surveys and Questionnaires; D000068737:Tolterodine Tartrate; D001743:Urinary Bladder / Q000503:physiopathology; D053202:Urinary Incontinence, Urge / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology*; D014563:Urodynamics / Q000502:physiology*
D001559:Benzhydryl Compounds; D003408:Cresols; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate